GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (NAS:ALBT) » Definitions » Debt-to-Equity

ALBT (Avalon Globocare) Debt-to-Equity : 1.61 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Avalon Globocare Debt-to-Equity?

Avalon Globocare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $6.90 Mil. Avalon Globocare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $1.82 Mil. Avalon Globocare's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $5.40 Mil. Avalon Globocare's debt to equity for the quarter that ended in Sep. 2024 was 1.61.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Avalon Globocare's Debt-to-Equity or its related term are showing as below:

ALBT' s Debt-to-Equity Range Over the Past 10 Years
Min: -9   Med: 0.48   Max: 17.28
Current: 1.61

During the past 10 years, the highest Debt-to-Equity Ratio of Avalon Globocare was 17.28. The lowest was -9.00. And the median was 0.48.

ALBT's Debt-to-Equity is ranked worse than
76.77% of 1558 companies
in the Real Estate industry
Industry Median: 0.735 vs ALBT: 1.61

Avalon Globocare Debt-to-Equity Historical Data

The historical data trend for Avalon Globocare's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare Debt-to-Equity Chart

Avalon Globocare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 0.91 1.07 0.41 1.15

Avalon Globocare Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 1.15 1.39 1.87 1.61

Competitive Comparison of Avalon Globocare's Debt-to-Equity

For the Real Estate Services subindustry, Avalon Globocare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avalon Globocare's Debt-to-Equity Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Avalon Globocare's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Avalon Globocare's Debt-to-Equity falls into.



Avalon Globocare Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Avalon Globocare's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Avalon Globocare's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avalon Globocare  (NAS:ALBT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Avalon Globocare Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Avalon Globocare's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Avalon Globocare Business Description

Traded in Other Exchanges
N/A
Address
4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Executives
Lourdes Felix director 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
W J Tauzin director 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Wenzhao Lu director, 10 percent owner C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Andrew Sanders director 431 EAST 20TH STREET, NEW YORK NY 10010
Yancen Lu director 14009 SE 50TH STREET, BELLEVUE WA 98006
Stilley William B. Iii director 1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE VA 22901
Tevi Troy director 611 SOMERSWORTH WAY, SILVER SPRING MD 20902
Luisa Ingargiola officer: Chief Financial Officer 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
David Jin director, officer: CEO and President C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Yue Charles Li director C/O AVALON GLOBOCARE CORP., 4400 ROUTE 9 SOUTH, SUITE 3100, FREEHOLD NJ 07728
Meng Li director, officer: Chief Operating Officer C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Philip Sukel director 33 ALPINE DRIVE, MORGANVILLE NJ 07751